Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home European Markets

Is Nel ASA’s Hydrogen Strategy Gaining Critical Momentum?

Dieter Jaworski by Dieter Jaworski
November 12, 2025
in European Markets, Hydrogen, Renewable Energy, Turnaround
0
Nel ASA Stock
0
SHARES
6
VIEWS
Share on FacebookShare on Twitter

Recent developments at Norwegian hydrogen specialist Nel ASA suggest the company may be reaching an inflection point. This week’s announcement of a strategic collaboration with GreenH AS for two new hydrogen production facilities follows closely on the heels of what the company described as the largest order in its history, potentially signaling a shift in fortunes for the equity.

Quarterly Challenges Offset by Major Contracts

Despite the recent positive developments, Nel faced significant headwinds in its most recent quarterly report released in late October:

  • Contract Revenue Decline: Customer contract revenues fell by 17 percent
  • Order Intake Contraction: New orders plummeted 64 percent year-over-year
  • EBITDA Improvement: The loss narrowed to -37 million NOK, a substantial improvement from the previous year’s -90 million NOK

These lackluster figures highlight why the subsequent major contract wins are viewed as particularly timely. Market observers now speculate whether these substantial orders could drive a meaningful recovery in the company’s order book over the coming quarters as Nel works to convert its extensive sales pipeline into firm contracts.

Record-Breaking U.S. Order Fuels Market Optimism

The current wave of positive news began with a landmark announcement on November 5. Nel’s U.S. subsidiary secured a firm purchase order valued at $50 million from Kaupanes Hydrogen and HyFuel AS. This contract involves supplying 40 MW of containerized PEM electrolyzers, representing the largest PEM electrolyzer order in Nel’s corporate history.

Should investors sell immediately? Or is it worth buying Nel ASA?

  • Delivery Schedule: Commencing second half of 2026 through 2027
  • Operational Timeline: Projected to become operational by early 2028
  • Market Response: Equity value surged by approximately 20 percent following the announcement

The initial investor enthusiasm, however, proved somewhat transient. In recent trading on Tradegate, the shares experienced a slight pullback, declining 0.4 percent.

GreenH Collaboration Adds to Project Pipeline

The newly unveiled partnership with GreenH covers development at two Norwegian sites—Kristiansund and Slagentangen. Each facility is planned with a minimum capacity of 10 MW, adding at least 20 MW of combined capacity to Nel’s project portfolio. Both initiatives form part of Norway’s national strategy to establish a comprehensive domestic hydrogen value chain and are receiving financial support from the state-owned enterprise Enova.

“We are pleased to support GreenH in developing regional hydrogen infrastructure across Norway,” stated CEO Håkon Volldal. Final contractual details for the projects remain under negotiation.

The convergence of these substantial contracts suggests Nel ASA may be positioning itself for a potential operational turnaround, though market participants continue to monitor whether this positive momentum can be sustained amid the challenging financial results reported just weeks earlier.

Ad

Nel ASA Stock: Buy or Sell?! New Nel ASA Analysis from March 25 delivers the answer:

The latest Nel ASA figures speak for themselves: Urgent action needed for Nel ASA investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 25.

Nel ASA: Buy or sell? Read more here...

Tags: Nel ASA
Dieter Jaworski

Dieter Jaworski

About Dieter Jaworski From a numbers-obsessed child to creating his first investment newsletter. Even as a child, Dieter Jaworski's mother couldn't believe how fascinated he was with numbers. This early passion for mathematics and data analysis laid the foundation for a successful career in financial markets and investment analysis.
Areas of Expertise:
  • Quantitative Analysis
  • Financial Newsletter Publishing
  • Data-Driven Investment Strategies
  • Market Pattern Recognition
Dieter's unique approach combines his natural affinity for numbers with decades of market experience, providing investors with data-driven insights and practical investment strategies.

Related Posts

XPeng Stock
Asian Markets

XPeng Achieves Profitability Milestone Amid Strategic Mexican Launch

March 25, 2026
Alphabet Stock
AI & Quantum Computing

Regulatory Scrutiny Looms Over Alphabet’s Aggressive AI Expansion

March 25, 2026
Hikma Stock
European Markets

Hikma Pharmaceuticals Moves to FTSE 250 After Index Review

March 24, 2026
Next Post
Gold Stock

Gold's Perfect Storm: Multiple Forces Converge

Applovin Stock

Applovin's AI Ambitions Fuel Record Growth Amid Market Concerns

Iqvia Stock

IQVIA Stock Surges on Strong Earnings and AI Focus

Recommended

Technology Blockchain Trading online

Analyst Reaffirms Bullish Outlook on CyberArk Software with 300 Price Target

2 years ago
Pepsi Stock

PepsiCo’s Leadership Shift Amid Market Headwinds

4 months ago
Nvidia Stock

Nvidia’s AI Dominance Faces Critical Test as Key Client Explores Alternatives

4 months ago
Palantir Stock

Palantir Shares Navigate Market Turbulence

4 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Regulatory Scrutiny Looms Over Alphabet’s Aggressive AI Expansion

Ocugen Shares Tumble Despite Positive Clinical Trial Results

Regulatory Proposal Sparks Sell-Off in Coinbase Shares

UnitedHealth Faces Multifaceted Regulatory Scrutiny Ahead of Earnings

Intel’s Capital Reshuffle and Leadership Transition Revealed in Annual Filing

35,000 Guards for 359 Million Doors: The Cyber Deficit Wall Street Can No Longer Ignore

Trending

Pinduoduo Stock
Asian Markets

Pinduoduo’s Upcoming Earnings: A Critical Test for the E-Commerce Giant

by SiterGedge
March 25, 2026
0

All eyes are on Pinduoduo this Wednesday as the company prepares to release its fourth-quarter 2025 financial...

XPeng Stock

XPeng Achieves Profitability Milestone Amid Strategic Mexican Launch

March 25, 2026
Oracle Stock

Oracle’s Backlog Soars on Cloud and AI Contract Momentum

March 25, 2026
Alphabet Stock

Regulatory Scrutiny Looms Over Alphabet’s Aggressive AI Expansion

March 25, 2026
Ocugen Stock

Ocugen Shares Tumble Despite Positive Clinical Trial Results

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Pinduoduo’s Upcoming Earnings: A Critical Test for the E-Commerce Giant
  • XPeng Achieves Profitability Milestone Amid Strategic Mexican Launch
  • Oracle’s Backlog Soars on Cloud and AI Contract Momentum

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com